Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANI PHARMACEUTICALS INC Director's Dealing 2011

Apr 1, 2011

31676_dirs_2011-04-01_463fffe5-9ba4-4418-ba52-74d8585aab5a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOSANTE PHARMACEUTICALS INC (BPAX)
CIK: 0001023024
Period of Report: 2011-03-31

Reporting Person: SULLIVAN LOUIS W (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-03-31 Non-Statutory Stock Option (right to buy) $1.98 A 25000 Acquired 2021-03-30 Common Stock (25000) Direct
2011-03-31 Non-Statutory Stock Option (right to buy) $1.98 A 10000 Acquired 2021-03-30 Common Stock (10000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 37898 Direct